Evolent Health Inc Market Cap ($470.17 Million)
Market Cap & Net Worth: Evolent Health Inc (EVH)
Evolent Health Inc market cap. Evolent Health Inc (NYSE:EVH) has a market capitalization of $470.17 Million ($470.17 Million) as of November 3, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #12243 globally and #3083 in its home market, demonstrating a -7.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Evolent Health Inc's stock price $4.45 by its total outstanding shares 112481067 (112.48 Million). Also see Evolent Health Inc (EVH) cash flow conversion for how efficiently the company converts equity into cash flow.
Evolent Health Inc Market Cap History (2015–2026)
Evolent Health Inc market cap history from 2015 to 2026. Data shows change from $1.36 Billion to $500.54 Million (-10.94% CAGR). Check current stock price of Evolent Health Inc for real-time trading data and today's change.
Evolent Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Evolent Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore EVH net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.24x
Evolent Health Inc's market cap is 0.24 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.66 Billion | $254.19 Million | -$159.74 Million | 6.55x | N/A |
| 2017 | $1.38 Billion | $434.95 Million | -$60.66 Million | 3.18x | N/A |
| 2018 | $2.24 Billion | $627.06 Million | -$52.66 Million | 3.58x | N/A |
| 2019 | $1.02 Billion | $687.12 Million | -$301.97 Million | 1.48x | N/A |
| 2020 | $1.80 Billion | $924.64 Million | -$334.25 Million | 1.95x | N/A |
| 2021 | $3.11 Billion | $907.96 Million | -$37.60 Million | 3.43x | N/A |
| 2022 | $3.16 Billion | $1.35 Billion | -$19.16 Million | 2.34x | N/A |
| 2023 | $3.72 Billion | $1.96 Billion | -$113.04 Million | 1.89x | N/A |
| 2024 | $1.27 Billion | $2.55 Billion | -$61.62 Million | 0.50x | N/A |
| 2025 | $449.92 Million | $1.88 Billion | -$534.51 Million | 0.24x | N/A |
Competitor Companies of EVH by Market Capitalization
Companies near Evolent Health Inc in the global market cap rankings as of November 3, 2026. Also see EVH total assets for a full breakdown of the balance sheet.
Key companies related to Evolent Health Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #717 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1658 globally with a market cap of $14.29 Billion USD ( AU$20.19 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2014 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #717 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $307.00 |
| #1658 | Pro Medicus Ltd | AU:PME | $14.29 Billion | AU$193.27 |
| #2014 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $78.48 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.26 |
Market Capitalization of Evolent Health Inc (2015–2026)
Market capitalization of Evolent Health Inc from 2015 to today. Between 2015 and today, Evolent Health Inc's market cap moved from $1.36 Billion to $ 500.54 Million, with a yearly change of -10.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $500.54 Million | +11.25% |
| 2025 | $449.92 Million | -64.44% |
| 2024 | $1.27 Billion | -65.94% |
| 2023 | $3.72 Billion | +17.63% |
| 2022 | $3.16 Billion | +1.48% |
| 2021 | $3.11 Billion | +72.61% |
| 2020 | $1.80 Billion | +77.13% |
| 2019 | $1.02 Billion | -54.64% |
| 2018 | $2.24 Billion | +62.20% |
| 2017 | $1.38 Billion | -16.89% |
| 2016 | $1.66 Billion | +22.21% |
| 2015 | $1.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Evolent Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $470.17 Million USD |
| MoneyControl | $470.17 Million USD |
| MarketWatch | $470.17 Million USD |
| marketcap.company | $470.17 Million USD |
| Reuters | $470.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics an… Read more